Biodesix announces appointment of successful innovator and scientific professional jon faiz kayyem, phd to board of directors

Boulder, colo.--(business wire)---- $bdsx #patientsfirst--biodesix, inc. (nasdaq: bdsx), a leading data-driven diagnostic solutions company with a focus in lung disease, announced the appointment of dr. jon faiz kayyem to the company's board of directors. dr. kayyem's diverse career spans more than 20 years and includes experience in academia, lean startups, and fortune 100 companies. he has served in various leadership positions throughout his career including numerous roles at genmark diagnostics, including founder,
BDSX Ratings Summary
BDSX Quant Ranking